| Preclinical efficacy of multi-targeting mRNA-based CAR T cell therapy in resection models of glioblastoma | Molecular therapy. Nucleic acids |  | | 2025 | 8 | 40 |
|
| Magnetic bead-sensitized optoporation coupled with antibodies-based activation for mRNA CAR-T cell manufacturing | Molecular therapy. Methods & clinical development | | | 2025 | 68 | 218 |
|
| PTPRZ1-targeting RNA CAR T cells exert antigen-specific and bystander antitumor activity in glioblastoma | Cancer immunology research | | | 2024 | 310 | 367 |
|
| Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages | Cell communication and signaling | | | 2024 | 145 | 82 |
|
| PTPRZ1-targeting RNA CAR-T cells exert antigen-specific and bystander antitumor activity in glioblastoma | | | | 2023 | 252 | 794 |
|
| Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy | Nature cancer | | | 2023 | 344 | 367 |
|
| Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma | Frontiers in Immunology | | | 2021 | 471 | 565 |
|
